Marco de Bruyn

14PUBLICATIONS
56CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Innate immunityEpidemiological modellingApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Sep 10, 2025
Upfront whole blood transcriptional patterns in patients receiving immune checkpoint inhibitors associate with clinical outcome.

S Hone Lopez, S Loipfinger, A Bhattacharya

|Aug 29, 2025
Spatiotemporal Immune Landscape and Long-term Immune Memory in POLE-Mutant Endometrial Cancer at the Single-Cell Level.

Koen Brummel, Marta Requesens, Nienke van Rooij

|May 13, 2025
Transcriptional pattern enriched for synaptic signaling is associated with shorter survival of patients with high-grade serous ovarian cancer.

Arkajyoti Bhattacharya, Thijs S Stutvoet, Mirela Perla

|Jan 24, 2025
Vvax001, a Therapeutic Vaccine, for Patients with HPV16-Positive High-grade Cervical Intraepithelial Neoplasia: A Phase II Trial.

Anneke L Eerkens, Martha D Esajas, Koen Brummel

|Sep 03, 2024
Neoadjuvant immune checkpoint blockade in women with mismatch repair deficient endometrial cancer: a phase I study.

Anneke L Eerkens, Koen Brummel, Annegé Vledder

|Jul 02, 2024
Immune predictors of response to immune checkpoint inhibitors in mismatch repair-deficient endometrial cancer.

Juan Francisco Grau Bejar, Elisa Yaniz Galende, Qinghe Zeng

Pageof 3

Frequent Collaborators

5 joint publications

Hans W Nijman

4 joint publications

Anneke L Eerkens

4 joint publications

Viktor Hendrik Koelzer

3 joint publications

René Wardenaar